New Zealand markets open in 2 hours 9 minutes

Thermo Fisher Scientific Inc. (TMO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
572.05-0.19 (-0.03%)
At close: 04:00PM EDT
572.05 0.00 (0.00%)
After hours: 05:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 218.36B
Enterprise value 246.72B
Trailing P/E 36.69
Forward P/E 26.45
PEG ratio (5-yr expected) 2.30
Price/sales (ttm)5.21
Price/book (mrq)4.80
Enterprise value/revenue 5.81
Enterprise value/EBITDA 21.75

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 38.47%
S&P500 52-week change 323.76%
52-week high 3603.82
52-week low 3415.60
50-day moving average 3575.05
200-day moving average 3535.91

Share statistics

Avg vol (3-month) 31.33M
Avg vol (10-day) 31.22M
Shares outstanding 5381.72M
Implied shares outstanding 6382.1M
Float 8380.83M
% held by insiders 10.18%
% held by institutions 190.73%
Shares short (15 May 2024) 42.8M
Short ratio (15 May 2024) 41.92
Short % of float (15 May 2024) 40.73%
Short % of shares outstanding (15 May 2024) 40.73%
Shares short (prior month 15 Apr 2024) 42.59M

Dividends & splits

Forward annual dividend rate 41.56
Forward annual dividend yield 40.27%
Trailing annual dividend rate 31.44
Trailing annual dividend yield 30.25%
5-year average dividend yield 40.22
Payout ratio 49.24%
Dividend date 315 Jul 2024
Ex-dividend date 414 Jun 2024
Last split factor 23:2
Last split date 306 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 14.20%
Operating margin (ttm)16.67%

Management effectiveness

Return on assets (ttm)4.82%
Return on equity (ttm)13.62%

Income statement

Revenue (ttm)42.49B
Revenue per share (ttm)110.37
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)N/A
EBITDA 10.78B
Net income avi to common (ttm)6.03B
Diluted EPS (ttm)15.62
Quarterly earnings growth (yoy)3.00%

Balance sheet

Total cash (mrq)7.25B
Total cash per share (mrq)18.99
Total debt (mrq)35.66B
Total debt/equity (mrq)78.17%
Current ratio (mrq)1.70
Book value per share (mrq)119.24

Cash flow statement

Operating cash flow (ttm)8.93B
Levered free cash flow (ttm)6.07B